Editorial: Advances in the Pathophysiology, Diagnosis, and Treatment of Dry Eye DiseaseYiteng Lu, Jiaxu Hong, Yuqing Wu et al.|Frontiers in Medicine|2022Cited by 15
A Supramolecular Deferoxamine–Crisaborole Nanoparticle Targets Ferroptosis, Inflammation, and Oxidative Stress in the Treatment of Retinal Ischemia/Reperfusion InjuryYiteng Lu, Yiyun Cheng, Nan Liu et al.|Nano Letters|2024Cited by 11
Identification of Matrix Metalloproteinase 3 as a Potential Biomarker for Dry Eye DiseaseXichen Wan, Jiaxu Hong, Mingrui Cheng et al.|Translational Vision Science & Technology|2025Cited by 5
Sphingomyelin Synthase 2 Deletion Mitigates Oxidative Stress-Induced NF-κB Activation via Lipid Metabolic Reprogramming in Dry Eye DiseaseYiteng Lu, Jiaxu Hong, Xichen Wan et al.|Investigative Ophthalmology & Visual Science|2025Cited by 2
Somatostatin Ameliorates Corneal Nerve Abnormalities and Inflammation Through Regulation of Macrophage Activities in Dry Eye DiseaseXingyu Zhu, Xujiao Zhou, Han Ye et al.|Investigative Ophthalmology & Visual Science|2025Cited by 1